TARGET
savePD-L1
Programmed death ligand 1; immune checkpoint ligand.
also known as: cd274, b7-h1, anti-pd-l1
🐶 often sniffed alongside
top 4drugs
0
catalysts
0
news
83
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- BMO most bullish on Merck's, bearish on BMS’ plans to contend with patent cliffsbiospace · 2d ago
- Summit snags $2B investment from AstraZeneca, clearing financial overhangbiospace · 6d ago
- Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADCbiospace · 7d ago
- Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study resultsbiopharma dive · 20d ago
- Summit, BioNTech, more headline WCLC with next-gen lung cancer drugsbiospace · 20d ago
- FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancerfiercebiotech · 24d ago
- Solstice rises with $225M series A to advance next-gen CTLA-4 immunotherapy into phase 2fiercebiotech · 26d ago
- Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancerbiospace · 26d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that